Aug 1, 2026

DSIR Recognition and Approval Services in India: A Practical Guide for R&D Organizations

Learn about DSIR recognition, Section 35(2AB) historical approvals, R&D centre registration, renewals, and compliance services. ACPL provides complete DSIR consultancy…

Jul 30, 2026

PESO (Petroleum and Explosives Safety Organisation) Registration & Licensing Services in India

PESO, or the Petroleum and Explosives Safety Organisation, stands as India’s central authority for keeping hazardous substances in check. They’re…

Jul 25, 2026

Navigating the Latest CDSCO Circular: What It Means for India’s Cosmetics Sector

Regulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs…

Jul 23, 2026

CDSCO Prohibits 16 Fixed Dose Combinations (FDCs): Key Regulatory Update for the Pharmaceutical Industry

CDSCO Bans 16 Fixed Dose Combinations: What Pharma Companies Need to Know Effective June 11, 2026, the Central Drugs Standard…

Jul 23, 2026

CDSCO Issues Final Guidance on Medical Device Software under MDR 2017: What Manufacturers Need to Know

Feb 26, 2026

CDSCO Circular (23–24 February 2026)

Key highlights from the CDSCO circular on “Testing of drugs for grant of permissions for import/manufacture of New Drug for…

Feb 23, 2026

Highlights of CDSCO Notification dated 16.02.2026

G.S.R. 135(E) – Changes to the Drugs Rules On February 16, 2026, the Central Drugs Standard Control Organization (CDSCO) rolled…

Feb 4, 2026

Trusted Regulatory Consultants in India for Business Compliance

Feb 4, 2026

Highlights and benefits of the recent U.S.–India trade agreement-Accredited Consultant Private Limited

Highlights and benefits of the recent U.S.–India trade agreement, with a focus on what it does (including tariff reductions) and…

Feb 3, 2026

India–EU Free Trade Agreement: What It Means for Business

India-EU Free Trade Agreement — The “Mother of All Deals” Big news on the trade front: On January 27, 2026,…